Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indices

Documenti analoghi

• EGCG enhances antitumor effect of apatinib in nonsmall cell lung cancer by targeting VEGF signaling to inhibit glycolysis
  di: Yue Zhou, et al.
  Pubblicazione: (2024)
• Tropisetron attenuates high glucose‐induced oxidative stress and inflammation in ARPE‐19 cells in vitro via regulating SIRT1/ROCK1 signaling
  di: Mingxia Tang, et al.
  Pubblicazione: (2024)
• MLLT3 knockdown suppresses proliferation and cell mobility in human lung adenocarcinoma
  di: Wenbo Shi, et al.
  Pubblicazione: (2024)
• Newly synthesized acridone derivatives targeting lung cancer: A toxicity and xenograft model study
  di: Nilam Bhusare, et al.
  Pubblicazione: (2024)
• Comparisons of successful and failed Phase III trials of drugs and biologicals tested for mitigation of oral mucositis in patients being treated with radiotherapy with or without concomitant chemotherapy for cancers of the head and neck
  di: Lang Liang, et al.
  Pubblicazione: (2024)